You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 69 No. 5, MAY 1942 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

USE OF ALPHA TOCOPHEROL IN THE TREATMENT OF NEUROMUSCULAR DISORDERS

ALBERT J. LUBIN, M.D.

Arch Intern Med. 1942;69(5):836-855.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

On the basis of experimental paralyses produced in animals by Evans and Burr,1 Einarson and Ringsted2 and others, vitamin E and alpha tocopherol, an alcohol isolated from wheat germ oil having apparently all of the properties of the vitamin, have been rather widely advocated as therapeutic agents for a variety of diseases of the neuromuscular system, especially amyotrophic lateral sclerosis and progressive muscular dystrophy. The favorable clinical reports of Bicknell3 and Wechsler4 have been followed by those of Stone,5 Vilter, Aring and Spies,6 and Rosenberger7 and by a considerable body of literature distributed by various pharmaceutic companies and, indeed, by the lay press. However, the reports of others8 make it clear that the efficacy of the therapy is far from proved.

This report covers a group of 35 patients treated with large doses of synthetic alpha tocopherol, beginning May 1940. The purpose of the study was to . . . [Full Text PDF of this Article]


Author Affiliations

SAN FRANCISCO

From the Department of Medicine (Division of Neuropsychiatry), Stanford University School of Medicine.


Footnotes

The synthetic alpha tocopherol was supplied by Merck & Co., Inc. and by Hoffmann-Laroche, Inc. through the cooperation of Dr. Herbert M. Evans, of the University of California.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1942 American Medical Association. All Rights Reserved.